BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37900572)

  • 1. PACAP regulates VPAC1 expression, inflammatory processes and lipid homeostasis in M1- and M2-macrophages.
    Witzel R; Block A; Pollmann S; Oetzel L; Fleck F; Bonaterra GA; Kinscherf R; Schwarz A
    Front Cardiovasc Med; 2023; 10():1264901. PubMed ID: 37900572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP deficiency aggravates atherosclerosis in ApoE deficient mice.
    Rasbach E; Splitthoff P; Bonaterra GA; Schwarz A; Mey L; Schwarzbach H; Eiden LE; Weihe E; Kinscherf R
    Immunobiology; 2019 Jan; 224(1):124-132. PubMed ID: 30447883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAC1 deficiency reduces chondrogenesis in atherosclerotic lesions of hypercholesterolemic ApoE-deficient mice.
    Blümm C; Bonaterra GA; Schwarzbach H; Eiden LE; Weihe E; Kinscherf R
    BMC Cardiovasc Disord; 2023 Nov; 23(1):566. PubMed ID: 37980508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages.
    Ackermann K; Bonaterra GA; Kinscherf R; Schwarz A
    Atherosclerosis; 2019 Feb; 281():128-136. PubMed ID: 30658188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation.
    Schwarz A; Bonaterra GA; Schwarzbach H; Kinscherf R
    J Biomed Sci; 2017 Feb; 24(1):12. PubMed ID: 28173800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAC1 deficiency attenuates progression of atherosclerosis in ApoE deficient mice under cholesterol-enriched diet.
    Splitthoff P; Rasbach E; Neudert P; Bonaterra GA; Schwarz A; Mey L; Schwarzbach H; Eiden LE; Weihe E; Kinscherf R
    Immunobiology; 2020 May; 225(3):151930. PubMed ID: 32173151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway.
    Bao MH; Lv QL; Li HG; Zhang YW; Xu BF; He BS
    Mediators Inflamm; 2020; 2020():6268514. PubMed ID: 32694928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein.
    de la Paz Sánchez-Martínez M; Blanco-Favela F; Mora-Ruiz MD; Chávez-Rueda AK; Bernabe-García M; Chávez-Sánchez L
    Lipids Health Dis; 2017 Oct; 16(1):196. PubMed ID: 29017604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.
    Langer I; Latek D
    Front Endocrinol (Lausanne); 2021; 12():711906. PubMed ID: 34867774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1.
    Arsiwala T; Pahla J; van Tits LJ; Bisceglie L; Gaul DS; Costantino S; Miranda MX; Nussbaum K; Stivala S; Blyszczuk P; Weber J; Tailleux A; Stein S; Paneni F; Beer JH; Greter M; Becher B; Mostoslavsky R; Eriksson U; Staels B; Auwerx J; Hottiger MO; Lüscher TF; Matter CM
    J Mol Cell Cardiol; 2020 Feb; 139():24-32. PubMed ID: 31972266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A.
    Voloshyna I; Teboul I; Kasselman LJ; Salama M; Carsons SE; DeLeon J; Mattana J; Miyawaki N; Reiss AB
    Inflamm Res; 2019 Sep; 68(9):787-799. PubMed ID: 31227843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J; Gomariz RP; Martinez C; Abad C; Ganea D; Delgado M
    Ann N Y Acad Sci; 2000; 921():92-102. PubMed ID: 11193883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
    J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT4 deficiency reduces the development of atherosclerosis in mice.
    Taghavie-Moghadam PL; Gjurich BN; Jabeen R; Krishnamurthy P; Kaplan MH; Dobrian AD; Nadler JL; Galkina EV
    Atherosclerosis; 2015 Nov; 243(1):169-78. PubMed ID: 26386214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.